Magistrate Judge's "Report and Recommendation" in RxUSA Wholesale, et al v. FDA

Production is set to take place at Samsung Biologics’ Songdo, South Korea, site, and the agreement will run through December 2030, subject to change.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Pharmapack identifies biologic approvals, drug delivery advancements, GLP-1 generics, and the return of funding flow as drivers for a record year in 2025.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

Kloxxado was approved by FDA in 2021 for emergency treatment of opioid overdose, and Emergent also distributes the FDA-approved over-the-counter treatment Narcan.